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Torsade de pointes (TdP) denotes a polymorphic ventricular tachycardia that is associated with 
prolonged QT interval at baseline, and is potentially life-threatening. Though it is well established 
that the genesis of TdP is closely linked to the transmural dispersion of repolarisation (TDR), the 
cellular and electrophysiological milieu predisposing to torsadogenesis in many conditions is not 
completely   understood   [1].                                                                                  
Significantly increased TDR at contiguous myocardial sites functions as a re-entrant substrate to 
initiate and maintain a TdP episode. Increased TDR in myocardium is represented by the 
electrocardiographic finding of prolonged QT interval. More specifically, the descending limb of 
the T wave represents TDR and this phase is considered to be a vulnerable period for 
torsadogenesis [2]. When a premature beat occurs in this period, the arrhythmia is initiated and 
perpetuated due to phase 2 re-entry or phase 2 early after depolarization.                        
Bradycardia is known to be one of the major factors predisposing to TdP. The inverse relationship 
between heart rate and repolarization time primarily accounts for bradycardia-induced QT 
prolongation. In addition, bradycardia increases the torsadogenicity of drugs that block IKr 
because these drugs block K+ channels in a reverse-use-dependent manner [3]. TdP has been 
described in many conditions with bradycardia like atrioventricular (AV) block, drugs, vagotonia, 
hypothyroidism etc [4-7]. However, patients with chronic AV block may have mechanisms other 
than the magnitude of bradycardia. Pause-dependent TdP has been recognised as an important 
complication of chronic AV block for long [8].  Studies have noted that patients with heart block 
have a significantly longer QT interval than those with sinus bradycardia even at comparable 
heart rates [9].  This relative QT prolongation may be one of the major reasons why TdP is more 
commonly observed in chronic AV block than in sinus bradycardia. However, the cellular 
mechanisms accounting for prolongation of repolarisation in them may be varied. Early after-
depolarisations may develop in these patients through prolongation of the action potential 
duration secondary to both bradycardia-dependent depression of electrogenic Na+ pumping and 
more complete inactivation of IK  [10]. In addition, low ventricular rates are associated with 
submaximal activation of ITO, which shifts plateau of the action potential to a voltage levels in 
which the Ca2+ window current availability is increased [11]. Fast heart rates tend to oppose these 
actions, preventing early after-depolarisations and TdP.                                                           
In this issue of the journal, Yiginer G et al report a retrospective analysis of 64 patients with 
chronic AV block for occurrence of TdP and its predictors [12]. The three patients who developed 
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TdP in this group were females, had more advanced age, and were in bradycardia for longer 
duration. The gender-specific preponderance in females to develop drug-induced TdP when 
treated with antiarrhythmic drugs or during spontaneous bradyarrhythmias is already known [13]. 
Elderly persons are more likely to have more co-morbid conditions like hypertension, coronary 
artery disease and heart failure, and these co-morbidities are known to cause down regulation of 
potassium channels [14]. Duration of exposure to bradycardia is another factor predisposing to 
TdP according to the authors. Concomitant to the duration of AV block, the likelihood of slower 
and irregular ventricular rhythms, which can result in ‘long-short’ sequence, may also increase. 
Chronicity of bradycardia might result in many alterations in myocardial channel functions also 
[15]. These alternate mechanisms also may contribute to an increase in the degree of the 
dispersion of refractory periods and facilitate the development of extrasystoles, thus playing a 
major role in producing TdP, apart from the magnitude of bradycardia, in patients with chronic 
AV   block.                                                                            
The authors identified that T wave notching on ECG having a predictive value for TdP, besides 
QT prolongation. All 3 cases who developed TdP had notched T waves in the ECG on the 
occurrence day of TdP, and in them, Tpeak-Tend were longer than 85 ms. This is concordant with 
the previous observations in similar group of patients. Bozkaya et al noted the presence of 
prolonged QTc/JTc intervals, pathologic U wave and T-U complex, prolonged Tpeak-Tend 
interval, and LQT2-like QT morphology as the predictors of ventricular arrhythmias during 
chronic AV block [16]. In another retrospective case-control study, where genetic testing was 
done in patients with TdP in the setting of complete AV block, the terminal phase of 
repolarization (Tpeak to Tend) was identified as a marker of an underlying cardiac ion channel 
abnormality. In this study, 4/11 (36%) patients with complete AV block and TdP had a genetic 
mutation identified involving ion channels responsible for cardiac repolarization involving hERG 
(n=3) and SCN5A (n=1).  Authors proposed TdP in the setting of complete AV block to represent 
the subset of patients with underlying genetic predisposition to reduced repolarization reserve 
[17].  
This study conveys a message that a subgroup of patients with chronic AV block are at higher 
risk to develop life-threatening ventricular arrhythmias. Presently, any of the predisposing factors 
identified by the authors - age, gender or duration of heart block- are not given added importance 
while recommending pacemaker implantation in patients with chronic AV block.  In real world 
scenario, large prospective randomised studies in patients with chronic AV block to assess the 
unintervened natural history of varying subgroups may not be possible because of multitude of 
reasons. Hence the recommendations are often supported only by evidence from retrospective 
observations. It is interesting to note that not a single recommendation (Class I-III) in the current 
ACC/AHA guidelines for pacing in bradycardia is backed up by level of evidence A [18]. In 
contrast, for both biventricular pacing and cardioverter-defebrillators, the benefits of implantation 
are   overwhelmingly   evidence-based.   The   reasons   for   this   apparent   paradox   could   be 
multifactorial. Pacemaker is clearly life saving at least in a selected population and may not need 
further evidence. Furthermore, only a few patients with unintervened natural history may be 
available to assess the long term outcome. These limitations leave a few clinical scenarios like 
asymptomatic chronic AV block with narrow QRS escape rhythm, especially while noted for the 
first time in adults, with limited evidence in favour of clear benefit with pacemaker implantation. 
Still, the present guidelines favour implantation as reasonable for persistent third-degree AV 
block with an escape  rate greater  than 40 bpm in asymptomatic adult patients without 
cardiomegaly (Indication: Class IIA, Level of Evidence: C). Interestingly, the recommendations 
do not consider QT prolongation as an indication for pacemaker implantation in these patients. 
Indeed, subsequent studies would be required to establish the incremental role of the high-risk 
predictors identified by Yiginer et al in further risk stratification of chronic AV block.  
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